Sorry, you need to enable JavaScript to visit this website.
Ochsner Health announces first enrollment for Phase 2/3 study of vaccine for Covid-19

Ochsner Health announced plans to participate as a study site for the Phase 2/3 global study sponsored by Pfizer Inc.

PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!

The Inquisitor

1915 Citizens Bank Drive
Bossier City, LA. 71111
(318) 929-5152